Clinical Trial Update: Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD) [NA]

View source ↗

Summary

This document reports an ongoing clinical trial evaluating RGMA001 in patients with non-alcoholic fatty liver disease; the status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• RGMA001

Snippet

Sponsor: Biovil Research Group, LLC | Conditions: Non Alcoholic Fatty Liver Disease | NA | Status: UNKNOWN